Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Home
Dermatology
Prof Vishalakshi Viswanath
Prof Vishalakshi Viswanath
20 Apr 2018
Dermatology
Share:
More great content like this
- straight to your inbox >
Related To This Subject
Dermatology
11th
April
Dr Michael Gold
Dermatology
11th
April
Dr Neal Bhatia
More articles
Dermatology
12 Sep 2025
The POSITIVE Phase IV Study: Interim 52-Week Results on Patient Well-Being With Tildrakizumab
Flagship Journal
3
Mins
11 Sep 2025
Development of Phage Therapies for Acne Vulgaris
Flagship Journal
5
Mins
11 Sep 2025
Anti-IL-23 Blocks Pathogenic T Cells
Featured journals
Dermatology
July 2025
AMJ Dermatology 2 [Supplement 4] 2025
Dermatology
May 2025
EMJ Dermatology 13 [Supplement 2] 2025
We’ve noticed you’re accessing
from
North/South America.
View
View
